SS
WST icon

SBI Securities’s West Pharmaceutical WST Stock Holding History

SBI Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.27K Sell
25
-805
-97% -$200K ﹤0.01% 1935
2025
Q4 		$228K Buy
830
+170
+26% +$46.5K 0.01% 593
2025
Q3 		$173K Buy
660
+618
+1,471% +$150K ﹤0.01% 669
2025
Q2 		$9.19K Sell
42
-3
-7% -$641 ﹤0.01% 1735
2025
Q1 		$10.1K Buy
45
+6
+15% +$1.65K ﹤0.01% 1603
2024
Q4 		$12.8K Buy
+39
New +$12.3K ﹤0.01% 1541

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SBI Securities's WST Position: Q1 2026 in Review

SBI Securities reduced its West Pharmaceutical (WST) stake by 97% in Q1 2026, selling an estimated $200K and leaving 25 shares worth $6.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1935.

SBI Securities first reported a position in WST in Q4 2024 and has held it in 6 quarters since. The position peaked at $228K in Q4 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • SBI Securities held 25 shares of West Pharmaceutical worth $6.27K as of Q1 2026.
  • SBI Securities sold 805 West Pharmaceutical shares in Q1 2026, an estimated $200K.
  • West Pharmaceutical made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1935 holding.
  • SBI Securities first reported a position in West Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's West Pharmaceutical position peaked at $228K in Q4 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.